• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

正常老年人的阿尔茨海默病标志物、高血压和灰质损伤。

Alzheimer's disease markers, hypertension, and gray matter damage in normal elderly.

机构信息

Center of Excellence on Aging, Center for Brain Health, Department of Psychiatry, New York University School of Medicine, New York, NY 10016, USA.

出版信息

Neurobiol Aging. 2012 Jul;33(7):1215-27. doi: 10.1016/j.neurobiolaging.2011.02.012. Epub 2011 May 6.

DOI:10.1016/j.neurobiolaging.2011.02.012
PMID:21530003
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3179821/
Abstract

It is not well known whether Alzheimer's disease (AD) cerebrospinal fluid (CSF) biomarkers are associated with brain damage in cognitively normal elderly. The combined influence of CSF biomarkers and hypertension (HTN) on the gray matter (GM) is also not well described. One hundred fifteen cognitively healthy subjects (mean age 62.6 ± 9.5%, 62% women) received clinical assessment, a high resolution magnetic resonance imaging (MRI), and a lumbar puncture. The CSF levels of total tau (t-tau), hyperphosphorylated tau (p-tau(231)), amyloid beta (Aβ42/Aβ40), p-tau(231)/Aβ42, and t-tau/Aβ42 were dichotomized as "high" and "low" based on accepted cut off values. Statistical parametric mapping was used to examine MRI scans for regional GM density, studied as a function of the CSF markers, HTN, and combination of both. Global and medial temporal lobe (MTL) GM was also assessed. Voxel based morphometry revealed that higher t-tau was associated with lower GM density in the precunei. Subjects with higher p-tau(231) and p-tau(231)/Aβ42 had less GM in temporal lobes. Low Aβ42/Aβ40 was related to less GM in the thalami, caudate, and midbrain. Subjects with hypertension showed more GM atrophy in the cerebellum, occipital, and frontal regions. Simultaneous presence of elevated CSF AD biomarkers and HTN was associated with more GM atrophy than either marker individually, but no interaction effects were identified. In conclusion, in normal elderly CSF tau markers were associated predominantly with lower GM estimates in structures typically affected early in the AD process. In this presymptomatic stage when no cognitive impairment is present, AD biomarkers and HTN have additive effects on gray matter damage.

摘要

目前尚不清楚阿尔茨海默病(AD)脑脊液(CSF)生物标志物是否与认知正常的老年人的脑损伤有关。CSF 生物标志物和高血压(HTN)对灰质(GM)的综合影响也描述得不够清楚。115 名认知健康的受试者(平均年龄 62.6±9.5%,62%为女性)接受了临床评估、高分辨率磁共振成像(MRI)和腰椎穿刺。脑脊液中总 tau(t-tau)、磷酸化 tau(p-tau(231))、淀粉样蛋白β(Aβ42/Aβ40)、p-tau(231)/Aβ42 和 t-tau/Aβ42 的水平根据公认的截断值被分为“高”和“低”。使用统计参数映射检查 MRI 扫描的区域性 GM 密度,研究其作为 CSF 标志物、HTN 和两者结合的函数。还评估了全脑和内侧颞叶(MTL)GM。基于体素的形态计量学显示,较高的 t-tau 与后扣带回 GM 密度降低有关。较高的 p-tau(231)和 p-tau(231)/Aβ42 与颞叶 GM 减少有关。低 Aβ42/Aβ40 与丘脑、尾状核和中脑 GM 减少有关。高血压患者小脑、枕叶和额叶 GM 萎缩更为明显。同时存在升高的 CSF AD 生物标志物和 HTN 与单独任何一种标志物相比,GM 萎缩更为明显,但未发现交互作用。总之,在正常老年人中,CSF tau 标志物主要与 AD 过程中早期受影响的结构中的 GM 估计值较低有关。在没有认知障碍的这个无症状阶段,AD 生物标志物和 HTN 对灰质损伤有相加作用。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fad1/3179821/132139969785/nihms292592f3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fad1/3179821/bdb0377bf67f/nihms292592f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fad1/3179821/05a4908e1ea9/nihms292592f2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fad1/3179821/132139969785/nihms292592f3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fad1/3179821/bdb0377bf67f/nihms292592f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fad1/3179821/05a4908e1ea9/nihms292592f2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fad1/3179821/132139969785/nihms292592f3.jpg

相似文献

1
Alzheimer's disease markers, hypertension, and gray matter damage in normal elderly.正常老年人的阿尔茨海默病标志物、高血压和灰质损伤。
Neurobiol Aging. 2012 Jul;33(7):1215-27. doi: 10.1016/j.neurobiolaging.2011.02.012. Epub 2011 May 6.
2
Longitudinal structural cerebral changes related to core CSF biomarkers in preclinical Alzheimer's disease: A study of two independent datasets.与临床前阿尔茨海默病核心 CSF 生物标志物相关的纵向结构脑变化:两项独立数据集研究。
Neuroimage Clin. 2018 Apr 16;19:190-201. doi: 10.1016/j.nicl.2018.04.016. eCollection 2018.
3
Correlations between Cerebrospinal Fluid Biomarkers and Gray Matter Atrophy in Alzheimer's and Behavioural Variant Frontotemporal Dementia.阿尔茨海默病和行为变异型额颞叶痴呆中脑脊液生物标志物与灰质萎缩的相关性
Curr Alzheimer Res. 2024;21(6):371-383. doi: 10.2174/0115672050330903240919074725.
4
MRI and CSF studies in the early diagnosis of Alzheimer's disease.磁共振成像(MRI)和脑脊液研究在阿尔茨海默病早期诊断中的应用
J Intern Med. 2004 Sep;256(3):205-23. doi: 10.1111/j.1365-2796.2004.01381.x.
5
Race modifies the relationship between cognition and Alzheimer's disease cerebrospinal fluid biomarkers.种族改变了认知与阿尔茨海默病脑脊液生物标志物之间的关系。
Alzheimers Res Ther. 2017 Nov 2;9(1):88. doi: 10.1186/s13195-017-0315-1.
6
Atrophy, metabolism and cognition in the posterior cortical atrophy spectrum based on Alzheimer's disease cerebrospinal fluid biomarkers.基于阿尔茨海默病脑脊液生物标志物的后部皮质萎缩谱中的萎缩、代谢和认知。
Neuroimage Clin. 2018;20:1018-1025. doi: 10.1016/j.nicl.2018.10.010. Epub 2018 Oct 10.
7
The association between biomarkers in cerebrospinal fluid and structural changes in the brain in patients with Alzheimer's disease.阿尔茨海默病患者脑脊液生物标志物与大脑结构变化的关系。
J Intern Med. 2014 Apr;275(4):418-27. doi: 10.1111/joim.12164. Epub 2013 Dec 11.
8
Data-driven CSF biomarker profiling: imaging and clinical outcomes in a cohort at risk of Alzheimer's disease.数据驱动的脑脊液生物标志物分析:阿尔茨海默病风险队列中的影像学和临床结果
Alzheimers Res Ther. 2024 Dec 23;16(1):274. doi: 10.1186/s13195-024-01629-y.
9
Phosphorylated tau 231, memory decline and medial temporal atrophy in normal elders.磷酸化 tau 231、记忆减退和正常老年人的内侧颞叶萎缩。
Neurobiol Aging. 2011 Dec;32(12):2131-41. doi: 10.1016/j.neurobiolaging.2009.12.026. Epub 2010 Feb 4.
10
Progressive medial temporal lobe atrophy during preclinical Alzheimer's disease.在临床前阿尔茨海默病期间进行性内侧颞叶萎缩。
Neuroimage Clin. 2017 Aug 25;16:439-446. doi: 10.1016/j.nicl.2017.08.022. eCollection 2017.

引用本文的文献

1
Neuroinflammation-mediated YKL-40 correlates with tau pathology and predicts longitudinal cognitive impairment and brain atrophy in Alzheimer's disease, with hypertensive dependency.神经炎症介导的YKL-40与tau病理相关,并预测阿尔茨海默病患者的纵向认知障碍和脑萎缩,且与高血压相关。
Front Aging Neurosci. 2025 Aug 6;17:1630022. doi: 10.3389/fnagi.2025.1630022. eCollection 2025.
2
Disrupted single-subject gray matter networks are associated with cognitive decline and cortical atrophy in Alzheimer's disease.在阿尔茨海默病中,单个受试者的灰质网络破坏与认知衰退和皮质萎缩相关。
Front Neurosci. 2024 May 10;18:1366761. doi: 10.3389/fnins.2024.1366761. eCollection 2024.
3
Shared whole environmental etiology between Alzheimer's disease and age-related macular degeneration.阿尔茨海默病与年龄相关性黄斑变性之间的共同整体环境病因。
NPJ Aging. 2024 Aug 5;10(1):36. doi: 10.1038/s41514-024-00162-4.
4
Beyond Hypertension: Examining Variable Blood Pressure's Role in Cognition and Brain Structure.超越高血压:探讨血压变异性在认知和脑结构中的作用。
J Gerontol B Psychol Sci Soc Sci. 2024 Sep 1;79(9). doi: 10.1093/geronb/gbae121.
5
Seeing beyond the symptoms: biomarkers and brain regions linked to cognitive decline in Alzheimer's disease.透过症状看本质:与阿尔茨海默病认知衰退相关的生物标志物和脑区
Front Aging Neurosci. 2024 May 15;16:1356656. doi: 10.3389/fnagi.2024.1356656. eCollection 2024.
6
The neutrophil to lymphocyte ratio associates with markers of Alzheimer's disease pathology in cognitively unimpaired elderly people.在认知未受损的老年人中,中性粒细胞与淋巴细胞的比例与阿尔茨海默病病理学标志物相关。
Immun Ageing. 2024 May 17;21(1):32. doi: 10.1186/s12979-024-00435-2.
7
The neutrophil to lymphocyte ratio associates with markers of Alzheimer's disease pathology in cognitively unimpaired elderly people.在认知未受损的老年人中,中性粒细胞与淋巴细胞的比例与阿尔茨海默病病理学标志物相关。
Res Sq. 2024 Mar 14:rs.3.rs-4076789. doi: 10.21203/rs.3.rs-4076789/v1.
8
Remote Associations Between Tau and Cortical Amyloid-β Are Stage-Dependent.tau 蛋白与皮质淀粉样蛋白-β 的远程关联具有阶段性。
J Alzheimers Dis. 2024;98(4):1467-1482. doi: 10.3233/JAD-231362.
9
Beyond Hypertension: Examining Variable Blood Pressure's Role in Cognition and Brain Structure.超越高血压:探究血压变异性在认知和脑结构中的作用。
medRxiv. 2024 Jan 16:2024.01.15.24301335. doi: 10.1101/2024.01.15.24301335.
10
Synergistic interaction of high blood pressure and cerebral beta-amyloid on tau pathology.高血压与脑β淀粉样蛋白对 tau 病理学的协同作用。
Alzheimers Res Ther. 2022 Dec 24;14(1):193. doi: 10.1186/s13195-022-01149-7.

本文引用的文献

1
Relationship between atrophy and beta-amyloid deposition in Alzheimer disease.阿尔茨海默病中萎缩与β-淀粉样蛋白沉积的关系。
Ann Neurol. 2010 Mar;67(3):317-24. doi: 10.1002/ana.21955.
2
Increased fibrillar amyloid-{beta} burden in normal individuals with a family history of late-onset Alzheimer's.家族中有晚发性阿尔茨海默病病史的正常个体中纤维状淀粉样-β负担增加。
Proc Natl Acad Sci U S A. 2010 Mar 30;107(13):5949-54. doi: 10.1073/pnas.0914141107. Epub 2010 Mar 15.
3
Lack of association between 11C-PiB and longitudinal brain atrophy in non-demented older individuals.在非痴呆的老年个体中,11C-PiB 与纵向脑萎缩之间无关联。
Neurobiol Aging. 2011 Dec;32(12):2123-30. doi: 10.1016/j.neurobiolaging.2009.12.008. Epub 2010 Feb 21.
4
Phosphorylated tau 231, memory decline and medial temporal atrophy in normal elders.磷酸化 tau 231、记忆减退和正常老年人的内侧颞叶萎缩。
Neurobiol Aging. 2011 Dec;32(12):2131-41. doi: 10.1016/j.neurobiolaging.2009.12.026. Epub 2010 Feb 4.
5
Glucose metabolism and PIB binding in carriers of a His163Tyr presenilin 1 mutation.携带早老素 1 突变 His163Tyr 的个体的葡萄糖代谢和 PIB 结合。
Neurobiol Aging. 2011 Aug;32(8):1388-99. doi: 10.1016/j.neurobiolaging.2009.08.016. Epub 2009 Sep 30.
6
Blood pressure and brain injury in older adults: findings from a community-based autopsy study.老年人血压与脑损伤:一项基于社区的尸检研究结果。
J Am Geriatr Soc. 2009 Nov;57(11):1975-81. doi: 10.1111/j.1532-5415.2009.02493.x. Epub 2009 Sep 28.
7
Association of white-matter lesions with brain atrophy markers: the three-city Dijon MRI study.脑白质病变与脑萎缩标志物的关联:第戎三城市MRI研究
Cerebrovasc Dis. 2009;28(2):177-84. doi: 10.1159/000226117. Epub 2009 Jun 25.
8
Large vessel cerebral atherosclerosis is not in direct association with neuropathological lesions of Alzheimer's disease.大脑大血管动脉粥样硬化与阿尔茨海默病的神经病理学病变无直接关联。
Eur Neurol. 2009;62(2):93-8. doi: 10.1159/000222779. Epub 2009 Jun 12.
9
Preclinical evidence of Alzheimer changes: convergent cerebrospinal fluid biomarker and fluorodeoxyglucose positron emission tomography findings.阿尔茨海默病改变的临床前证据:脑脊液生物标志物与氟脱氧葡萄糖正电子发射断层扫描结果的一致性
Arch Neurol. 2009 May;66(5):632-7. doi: 10.1001/archneurol.2009.59.
10
Alzheimer's disease neuroimaging initiative: a one-year follow up study using tensor-based morphometry correlating degenerative rates, biomarkers and cognition.阿尔茨海默病神经影像学计划:一项使用基于张量的形态测量法对退化率、生物标志物和认知进行相关性研究的一年随访研究。
Neuroimage. 2009 Apr 15;45(3):645-55. doi: 10.1016/j.neuroimage.2009.01.004.